Taylor Schreiber

Director at Kayak Therapeutics.

Earliest Form D on file: May 2026

Filed May 27, 2026

Kayak Therapeutics

TRIM7 inhibitors for RAS-driven solid tumors

Biotech, Austin TX

Named, Director.

$11.94M

sold of $25M offered

Network

At Kayak Therapeutics

3 people

Conor Richardson
Executive Officer, signed as Chief Financial Officer
Josiah Hornblower
Executive Officer, Director
Tyler Brous
Director